Clinical trial on in situ bone tissue engineering using bioactive bone substitute for acceleration of bone regeneration in sinus floor augmentation

Clinical trial on in situ bone tissue engineering using bioactive bone substitute for acceleration of bone regeneration in sinus floor augmentation - Clinical trial using bioactive bone substitute in sinus floor augmentation

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000005919

Enrollment

Registered

2011-07-11

Start date

2011-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrophic maxillary alveolar bone

Interventions

FGF-2/Hydroxyapatite

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The case of dental implantation in the region of maxillary molar with sinus floor augmentation

Exclusion criteria

Exclusion criteria: Excluding persons are tumor bearer, cancer history, a pregnant woman an expectant mother and parity pregnancy

Design outcomes

Primary

Measure	Time frame
Sinus floor augmentation using FGF-2/hydroxyapatite composite is safety technique and shorten treatment period.	—

Countries

Japan

Contacts

Public ContactMatsuno Tomonori

The Nippon Dental University, School of Life Dentistry at Tokyo Depertment of Oral & Maxillofacial Surgery

matsunot@tky.ndu.ac.jp03-3512-0404

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026